tiprankstipranks
Eterna Therapeutics Inc. (ERNA)
:ERNA
US Market

Eterna Therapeutics (ERNA) Income Statement

Compare
258 Followers

Eterna Therapeutics Income Statement

Last quarter (Q3 2024), Eterna Therapeutics's total revenue was $487.00K, an increase of 854.90% from the same quarter last year. In Q3, Eterna Therapeutics's net income was $-26.60M. See Eterna Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 582.00K$ 68.00K$ 0.00$ 0.00$ 0.00
Gross Profit
$ 486.00K$ -168.00K$ -497.00K$ -459.00K$ -98.00K
Operating Expenses
$ 17.74M$ 20.97M$ 27.23M$ 27.43M$ 7.25M
Depreciation and Amortization
$ 0.00$ 1.12M$ 497.00K$ 459.00K$ 98.00K
EBITDA
$ -15.67M$ -19.93M$ -33.22M$ -121.95M$ -7.15M
Operating Income
$ -15.67M$ -21.14M$ -33.22M$ 68.34M$ -7.25M
Other Income/Expenses
$ -28.84M$ -536.00K$ 8.68M$ -95.05M$ -19.28M
Pretax Income
$ -44.51M$ -21.67M$ -24.53M$ -122.30M$ -7.29M
Net Income
$ -44.55M$ -21.67M$ -24.58M$ -122.31M$ 11.91M
Per Share Metrics
Basic EPS
$ -3.26$ -4.08$ -8.06$ -56.49$ 27.08
Diluted EPS
$ -3.26$ -4.08$ -8.06$ -56.49$ 27.08
Weighted Average Shares Outstanding
13.65M 5.31M 3.05M 2.17M 439.70K
Weighted Average Shares Outstanding (Diluted)
13.65M 5.31M 3.05M 2.17M 439.70K
Currency in USD

Eterna Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis